- €1.00bn
- €569.49m
- €1.60bn
- 82
- 47
- 97
- 92
Annual income statement for Rhoen Klinikum AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,360 | 1,402 | 1,446 | 1,464 | 1,596 |
| Cost of Revenue | |||||
| Gross Profit | 938 | 972 | 1,000 | 976 | 1,060 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,350 | 1,372 | 1,410 | 1,423 | 1,547 |
| Operating Profit | 10.4 | 30 | 36.3 | 40.9 | 48.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.93 | 27.4 | 33.6 | 47.7 | 56.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.46 | 30.2 | 26.9 | 40.2 | 45.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.45 | 28.3 | 25.1 | 38.7 | 43.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.45 | 28.3 | 25.1 | 38.7 | 43.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.118 | 0.431 | 0.337 | 0.581 | 0.648 |
| Dividends per Share |